Nucleic Acid Aptamers Market Size is valued at USD 217.3 Mn in 2023 and is predicted to reach USD 732.5 Mn by the year 2031 at a 16.7% CAGR during the forecast period for 2024-2031. Nucleic acid aptamers are concise, individual strands of DNA or RNA that have a strong affinity for certain targets, such as proteins or tiny molecules. They are chosen via a procedure known as SELEX and are recognized for their stability, strong attraction, and mi...
Report ID: 2650 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
The Specimen Collection Cards Market Size is valued at 422.97 Mn in 2022 and is predicted to reach 660.55 Mn by the year 2031 at a 5.2 % CAGR during the forecast period for 2023-2031. Small amounts of blood are spotted on filter paper, dried, and then analysed in a process known as dried blood spots (DBS). The procedure was developed to identify phenylketonuria, a hereditary metabolic disorder, in newborns. Recently evolving dried blood spot (...
Report ID: 1985 |
Delivery: Immediate |
Published: February 2025 |
No. of Pages: 180
The Cell & Gene Therapy Raw Material Testing Market Size is valued at 1462.5 Million in 2022 and is predicted to reach 6822.6 Million by the year 2031 at an 18.8 % CAGR during the forecast period for 2023-2031. Cell and gene therapy is critical for treating life-threatening disorders such as cancer, leukemia, and cardiovascular disease. It is also necessary for advanced therapy medical products (ATMPs), which use genes and tissues as the b...
Report ID: 1327 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
Plasma Fractionation Market Size is valued at USD 4.2 Bn in 2023 and is predicted to reach USD 8.9 Bn by the year 2031 at a 10.1 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The demand for plasma-derived therapies has been increasing due to the rising prevalence of immune deficiencies, respiratory infections, including other disorders. Increased awareness and improved diagnostic ...
Report ID: 2140 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 179
The CAR-T Cell Therapy for Multiple Myeloma Market is expected to grow at a 27.0 % CAGR during the forecast period for 2023-2031. Chimeric Antigen Receptor (CAR) T cell therapy is an innovative treatment that encompasses the reengineering of white blood cells (WBC) of a cancer patient’s to fight the malignant cells by identifying them. CAR-T cell therapy is approved for certain types of blood cancer. The blood cancer type, multiple myelo...
Report ID: 1088 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 140
The CD Targeted Cell Therapy Market Size is valued at XX Million in 2022 and is predicted to reach XX Million by the year 2031 at an XX % CAGR during the forecast period for 2023-2031. InsightAce Analytic’s “Global CD Targeted Cell Therapy Market Research Report 2021” is a comprehensive analysis, forecast, market dynamics, and major trends report, covering critical market data on the CD targeted cell therapy target type segme...
Report ID: 1134 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Biomanufacturing Viral Detection and Quantification Market Size is valued at 466.52 Million in 2022 and is predicted to reach 981.41 Million by the year 2031 at a 8.8% CAGR during the forecast period for 2023-2031. Viral clearance is necessary during the downstream purification of therapeutic biologics, blood, and tissue-derived materials. Viruses are either removed or inactivated for manufacturing microbiologically stable goods. Rel...
Report ID: 1918 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
The Next Generation Genome Editing Market Size is predicted to develop with a CAGR of 21.8% during the forecast period for 2024-2031. The Next Generation Genome Editing market is rapidly advancing with technologies that enhance the capabilities of CRISPR-Cas9, addressing its limitations and expanding its potential. These advancements provide improved precision, efficiency, and the ability to make large-scale DNA modifications. Key innovations ...
Report ID: 2609 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
Personalized Genomics Market Size is valued at USD 7.97 Billion in 2022 and is predicted to reach USD 32.15 Billion by the year 2031 at a 16.96% CAGR during the forecast period for 2023-2031. Personalized genomics entails the examination of an individual's distinct genetic composition in order to customize medical treatment. It evaluates the likelihood of developing a disease, directs cancer treatment by analyzing genetic characteristics, and ...
Report ID: 2273 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
Emerging Infectious Disease Diagnostics Market Size is valued at US$ 19.23 Bn in 2022 and is predicted to reach US$ 31.76 Bn by the year 2031 at an 5.9% CAGR during the forecast period for 2023-2031. Infectious disease diagnosis is a diagnostic procedure in which various diagnostic tools are used to detect and characterise the causative organisms of infectious diseases. The COVID-19 pandemic certainly affected the market for infectious diseas...
Report ID: 2270 |
Delivery: Immediate |
Published: October 2024 |
No. of Pages: 180
Pharmaceuticals